Nucleic acid encoding N-methylputrescine oxidase and uses thereof
View Patent ↗The gene encoding N-methylputrescine oxidase (MPO) and constructs comprising such DNA are provided, including methods of regulating MPO expression independently or with other alkaloid biosynthesis genes to modulate alkaloid production in plants and host cells. MPO genes or fragments thereof are useful for reducing pyrrolidine or tropane alkaloid production in plants, for increasing pyrrolidine or tropane alkaloid production in plants, and for producing an MPO enzyme in host cells.
1. An increased alkaloid plant produced by a method of increasing N-methylputrescine oxidase (MPO) enzyme in a plant comprising:
(a) introducing into the plant a nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
(i) a nucleotide sequence set forth in SEQ ID NO: 1;
(ii) a nucleotide sequence set forth in SEQ ID NO: 2;
(iii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 3:
(iv) a nucleotide sequence that is at least 85% identical to the nucleotide sequences of (i), (ii), or (iii) and encodes an MPO enzyme;
(v) a nucleotide sequence that hybridizes under stringent conditions to the nucleotide sequences of (i), (ii), (iii), or (iv) and encodes an MPO enzyme; and
(vi) a nucleotide sequence that differs from the nucleic acid sequence of (i) or (ii) due to the degeneracy of the genetic code and encodes an MPO enzyme; and
(b) growing the plant under conditions whereby the nucleic acid molecule is expressed thereby increasing levels of MPO enzyme in the plant compared to a control plant grown under similar conditions.
2. The increased alkaloid plant of claim 1 , wherein the plant is a member of family Solanaceae or family Erythroxylaceae.
3. The increased alkaloid plant of claim 1 , wherein the plant is a member of genus Nicotiana, Datura, Airopa, Duboisia, Hyoscyamus, Mandragora, Brugmansia, Scopolia , or Erythroxylon.
4. The increased alkaloid plant of claim 1 , wherein the level of a tropane alkaloid is increased.
5. The increased alkaloid plant of claim 4 , wherein said tropane alkaloid is cocaine or scopolamine.
6. The increased alkaloid plant of claim 1 , wherein the level of a nicotinic alkaloid is increased.
7. The increased alkaloid plant of claim 6 , wherein the level of said nicotinic alkaloid is increased by introducing into the plant the nucleic acid molecule encoding MPO and a nucleotide sequence encoding at least one enzyme selected from the group consisting of NBB1, A622, quinolinate phosphoribosyl transferase (QPT), and putrescine N-methyltransferase (PMT), and wherein the plant has increased levels of MPO and at least one enzyme selected from the group consisting of NBB1, A622, QPT, and PMT.
8. The increased alkaloid plant of claim 6 or 7 , wherein the level of nicotine is increased.
9. An increased alkaloid tobacco product produced from a plant of any of claims 1 - 3 or 6 - 7 .
10. The increased alkaloid tobacco product of claim 9 , wherein said product is a pharmaceutical or nutraceutical.
11. The increased alkaloid tobacco product of claim 9 , wherein said increased alkaloid tobacco product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, pipe tobacco, chewing tobacco, snus, and tobacco lozenges.